Can the gut be the missing piece in uncovering PD pathogenesis?

Edwards, 1992, Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology, Neurology, 42, 726, 10.1212/WNL.42.4.726 Wakabayashi, 1988, Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses, Acta Neuropathol., 76, 217, 10.1007/BF00687767 Beach, 2010, Arizona Parkinson's Disease Consortium, Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders, Acta Neuropathol., 119, 689, 10.1007/s00401-010-0664-3 Gelpi, 2014, Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders, Mov. Disord., 29, 1010, 10.1002/mds.25776 Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol. Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 Braak, 2006, Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology, Neurosci. Lett., 396, 67, 10.1016/j.neulet.2005.11.012 Borghammer, 2018, How does Parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology, Mov. Disord., 33, 48, 10.1002/mds.27138 Lionnet, 2018, Does Parkinson's disease start in the gut?, Acta Neuropathol., 135, 1, 10.1007/s00401-017-1777-8 Sudo, 2004, Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice, J. Physiol., 558, 263, 10.1113/jphysiol.2004.063388 McCorry, 2007, Physiology of the autonomic nervous system, Am. J. Pharmaceut. Educ., 71, 78, 10.5688/aj710478 Lilly, 1992, The hypothalamic-pituitary-adrenal-immune axis. A critical assessment, Arch. Surg., 127, 1463, 10.1001/archsurg.1992.01420120097017 Schemann, 2004, The human enteric nervous system, Neuro Gastroenterol. Motil., 16, 55, 10.1111/j.1743-3150.2004.00476.x Jessen, 1983, Astrocyte-like glia in the peripheral nervous system: an immunohistochemical study of enteric glia, J. Neurosci., 3, 2206, 10.1523/JNEUROSCI.03-11-02206.1983 Gribble, 2016, Enteroendocrine cells: chemosensors in the intestinal epithelium, Annu. Rev. Physiol., 78, 277, 10.1146/annurev-physiol-021115-105439 Marchiando, 2010, Epithelial barriers in homeostasis and disease, Annu. Rev. Pathol., 5, 119, 10.1146/annurev.pathol.4.110807.092135 Suzuki, 2013, Regulation of intestinal epithelial permeability by tight junctions, Cell. Mol. Life Sci., 70, 631, 10.1007/s00018-012-1070-x Bhattarai, 2018, Microbiota-gut-brain axis: interaction of gut microbes and their metabolites with host epithelial barriers, Neuro Gastroenterol. Motil., 30 Michel, 2016, One more role for the gut: microbiota and blood brain barrier, Ann. Transl. Med., 4, 15 Erny, 2015, Host microbiota constantly control maturation and function of microglia in the CNS, Nat. Neurosci., 18, 965, 10.1038/nn.4030 Scheperjans, 2015, Gut microbiota are related to Parkinson's disease and clinical phenotype, Mov. Disord., 30, 350, 10.1002/mds.26069 Keshavarzian, 2015, Colonic bacterial composition in Parkinson's disease, Mov. Disord., 30, 1351, 10.1002/mds.26307 Unger, 2016, Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls, Park. Relat. Disord., 32, 66, 10.1016/j.parkreldis.2016.08.019 Bedarf, 2017, Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients, Genome Med., 9, 39, 10.1186/s13073-017-0428-y Hill-Burns, 2017, Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome, Mov. Disord., 32, 739, 10.1002/mds.26942 Heintz-Buschart, 2018, The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder, Mov. Disord., 33, 88, 10.1002/mds.27105 Hasegawa, 2015, Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease, PloS One, 10, 10.1371/journal.pone.0142164 Petrov, 2017, Analysis of gut microbiota in patients with Parkinson's disease, Bull. Exp. Biol. Med., 162, 734, 10.1007/s10517-017-3700-7 Hopfner, 2017, Gut microbiota in Parkinson disease in a northern German cohort, Brain Res., 1667, 41, 10.1016/j.brainres.2017.04.019 Li, 2017, Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features, Sci. China Life Sci., 60, 1223, 10.1007/s11427-016-9001-4 Qian, 2018, Alteration of the fecal microbiota in Chinese patients with Parkinson's disease, Brain Behav. Immun., 70, 194, 10.1016/j.bbi.2018.02.016 Sampson, 2016, Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease, Cell, 167, 1469, 10.1016/j.cell.2016.11.018 Choi, 2018, Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice, Sci. Rep., 8, 1275, 10.1038/s41598-018-19646-x Bialecka, 2007, CARD15 variants in patients with sporadic Parkinson's disease, Neurosci. Res., 57, 473, 10.1016/j.neures.2006.11.012 Liu, 2015, Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations, Nat. Genet., 47, 979, 10.1038/ng.3359 Hui, 2018, Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease, Sci. Transl. Med., 10, 10.1126/scitranslmed.aai7795 Villumsen, 2018 Peter, 2018, Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease, JAMA Neurol, 10.1001/jamaneurol.2018.0605 Lai, 2014, Irritable bowel syndrome correlates with increased risk of Parkinson's disease in Taiwan, Eur. J. Epidemiol., 29, 57, 10.1007/s10654-014-9878-3 Mertsalmi, 2017, More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota, Eur. J. Neurol., 24, 1375, 10.1111/ene.13398 Devos, 2013, Colonic inflammation in Parkinson's disease, Neurobiol. Dis., 50, 42, 10.1016/j.nbd.2012.09.007 Rühl, 2001, Interleukin-6 expression and regulation in rat enteric glial cells, Am. J. Physiol. Gastrointest. Liver Physiol., 280, G1163, 10.1152/ajpgi.2001.280.6.G1163 Clairembault, 2014, Enteric GFAP expression and phosphorylation in Parkinson's disease, J. Neurochem., 130, 805, 10.1111/jnc.12742 Pellegrini, 2016, Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration, J. Neuroinflammation, 13, 146, 10.1186/s12974-016-0608-5 Teismann, 2003, Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration, Proc. Natl. Acad. Sci. U.S.A., 100, 5473, 10.1073/pnas.0837397100 Pochard, 2018, Cyclooxygenase 2 is upregulated in the gastrointestinal tract in Parkinson's disease, Mov. Disord., 33, 493, 10.1002/mds.27237 Houser, 2018, Stool immune profiles evince gastrointestinal inflammation in Parkinson's disease, Mov. Disord., 33, 793, 10.1002/mds.27326 Schwiertz, 2018, Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease, Park. Relat. Disord., 50, 104, 10.1016/j.parkreldis.2018.02.022 Hirsch, 2012, Neuroinflammation in Parkinson's disease, Park. Relat. Disord., 18, S210, 10.1016/S1353-8020(11)70065-7 Gerhard, 2006, In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease, Neurobiol. Dis., 21, 404, 10.1016/j.nbd.2005.08.002 Stokholm, 2017, Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study, Lancet Neurol., 16, 789, 10.1016/S1474-4422(17)30173-4 Piche, 2009, Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators, Gut, 58, 196, 10.1136/gut.2007.140806 Katz, 1989, Intestinal permeability in patients with Crohn's disease and their healthy relatives, Gastroenterology, 97, 927, 10.1016/0016-5085(89)91499-6 Hollander, 1999, Intestinal permeability, leaky gut, and intestinal disorders, Curr. Gastroenterol. Rep., 1, 410, 10.1007/s11894-999-0023-5 Davies, 1996, Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease, Postgrad. Med., 72, 164, 10.1136/pgmj.72.845.164 Salat-Foix, 2012, Increased intestinal permeability and Parkinson disease patients: chicken or egg?, Can. J. Neurol. Sci., 39, 185, 10.1017/S0317167100013202 Forsyth, 2011, Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease, PloS One, 6, 10.1371/journal.pone.0028032 Clairembault, 2015, Structural alterations of the intestinal epithelial barrier in Parkinson's disease, Acta Neuropathol Commun, 3, 12, 10.1186/s40478-015-0196-0 Bohórquez, 2014, An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy, PloS One, 9, 10.1371/journal.pone.0089881 Chandra, 2017, α-Synuclein in gut endocrine cells and its implications for Parkinson's disease, JCI Insight, 2, 10.1172/jci.insight.92295 Lin, 2018, Gut microbiota in patients with Parkinson's disease in southern China, Park. Relat. Disord., 53, 82, 10.1016/j.parkreldis.2018.05.007 Tetz, 2018, Parkinson's disease and bacteriophages as its overlooked contributors, Sci. Rep., 8, 10812, 10.1038/s41598-018-29173-4